Lexaria Bioscience (LEXX) Earnings Date & Reports

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

LEXX is expected to report earnings to fall 5.03% to -15 cents per share on July 18

Lexaria Bioscience LEXX Stock Earnings Reports

Q2'25

Est.

$-0.16

Q1'25

Est.

$-0.17

Q4'24

Missed

by $0.08

Q3'24

Missed

by $0.02

Q2'24

Est.

$-0.13

The last earnings report on April 15 showed earnings per share of -16 cents, beating the estimate of -17 cents. With 70.49K shares outstanding, the current market capitalization sits at 20.93M.

View a ticker or compare two or three

Compare

LEXX